Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-21

Clinical Trial Update: Study on Tolerability of Levodopa/Carbidopa in Children With Angelman Syndrome [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated the tolerability of levodopa/carbidopa in children with Angelman syndrome. The trial has completed, and results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levodopa/Carbidopa (levodopa/carbidopa)

Snippet

Sponsor: Boston Children's Hospital | Conditions: Angelman Syndrome | Phase 1 | Status: COMPLETED | Results posted: 2016-11-21